Affiliation:
1. Department of Nursing Science University of Eastern Finland Kuopio Finland
2. Northern Finland Birth Cohorts, Arctic Biobank, Infrastructure for Population Studies, Faculty of Medicine University of Oulu Oulu Finland
3. Reseach Unit of Health Sciences and Technology, Faculty of Medicine University of Oulu Oulu Finland
4. Medical Research Center Oulu (MRC Oulu), Faculty of medicine University of Oulu Oulu Finland
Abstract
AbstractBackgroundIncreased knowledge of the concept of adherence is needed for development patient‐centered care, nursing interventions, and guidelines for patients with coronary heart disease (CHD). The aim of this study was to test and extend the Theory of Adherence to Treatment regarding informational support in patients with CHD.MethodsThe study utilized an explanatory and descriptive survey. The study was conducted in 2013 and involved 416 patients in five hospitals in Finland. The Adherence of Patients with Chronic Disease instrument and the Social Support for People with CHD instrument were used. The model was tested using structural equation modeling (SEM).ResultsSEM confirmed direct associations between motivation (β = 0.49, p < 0.001) and results of care (β = 0.29, p < 0.01), and indirect associations between sense of normality, fear of complications, support from nurses and next of kin, and informational support to adherence to a healthy lifestyle and medication. Informational support included information and advice on CHD risk factors, physical exercise, chest pain, medication, continuum of care, and rehabilitation. Indirect standardized path coefficients varied between 0.14 and 0.45. The model explained 45% of adherence to a healthy lifestyle and medication.ConclusionThe results of this study showed that informational support is a justified extension to the original Theory of Adherence to Treatment in Patients with CHD. Informational support seems to offer a new perspective that can be used to develop patient‐centered nursing interventions and thus support adherence to treatment by patients with a lifelong disease such as CHD.